Schonfeld Strategic Advisors LLC decreased its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 91.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 44,100 shares of the company's stock after selling 448,595 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Oscar Health were worth $593,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of OSCR. Park West Asset Management LLC lifted its stake in Oscar Health by 186.9% in the 4th quarter. Park West Asset Management LLC now owns 925,000 shares of the company's stock worth $12,432,000 after purchasing an additional 602,585 shares in the last quarter. Northern Trust Corp lifted its position in shares of Oscar Health by 9.8% in the fourth quarter. Northern Trust Corp now owns 1,947,779 shares of the company's stock worth $26,178,000 after buying an additional 174,106 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in Oscar Health by 0.8% during the fourth quarter. The Manufacturers Life Insurance Company now owns 355,832 shares of the company's stock valued at $4,782,000 after buying an additional 2,760 shares during the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in Oscar Health during the 4th quarter valued at approximately $616,000. Finally, Gilder Gagnon Howe & Co. LLC increased its stake in Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.
Oscar Health Stock Performance
NYSE:OSCR opened at $17.11 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock's fifty day moving average is $13.34 and its 200 day moving average is $14.64. The firm has a market capitalization of $4.29 billion, a PE ratio of -855.07 and a beta of 1.75. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business's revenue was up 42.2% on a year-over-year basis. During the same quarter last year, the business earned $0.62 EPS. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Analyst Ratings Changes
Separately, Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $20.08.
Read Our Latest Research Report on Oscar Health
Oscar Health Company Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
